Clinical Trial

Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a multicenter, open-label extension (OLE) study of MHB018A in subjects with moderate-to-severe TED.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-27.
Trial Details
NCT Number NCT07620405
Lead Sponsor Minghui Pharmaceutical (Hangzhou) Ltd
Conditions Thyroid Eye Disease (TED)
Enrollment 219 participants
Start Date 2027-07
Primary Completion 2030-01 (estimated)
Study Completion 2031-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-04